Companies / Creative Biolabs / Anti-FMC63 scFv Monoclonal Antibody, FITC-Conjugated
Creative Biolabs

Anti-FMC63 scFv Monoclonal Antibody, FITC-Conjugated | Creative Biolabs

FMC63 is a CD19-specific IgG1 mouse monoclonal antibody, which is a target for immunotherapy of B-lineage leukemia and lymphoma. FMC63 scFv is the most commonly used extracellular domain component of CD19-specific CARs. So far, most of the reported CART-CD19 clinical trials contain anti-CD19 scFv derived from FMC63, such as the two FDA-approved CARs Kymriah and Yescarta. This product was verified to specifically recognize the antigen recognition domain of FMC63-derived CAR.

Supporting Documents


Data Sheet

Datasheet

Reviews


No reviews yet

ABOUT THE COMPANY

Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.